A randomized, double-blinded, placebo-controlled clinical trial of sterile filtered human amniotic fluid for treatment of COVID-19

A randomized, double-blinded, placebo-controlled clinical trial of sterile filtered human amniotic fluid for treatment of COVID-19

Abstract Importance Acellular human amniotic fluid (hAF) is an antimicrobial and anti-inflammatory fluid that has been used to treat various pro-inflammatory conditions. In a feasibility study, we have previously demonstrated that hAF could be safely administered to severely ill patients with corona...

Descripció completa

Dades bibliogràfiques
Autors principals: Joseph E. Tonna, Jan Pierce, Benjamin J. Brintz, Tyler Bardsley, Nathan Hatton, Giavonni Lewis, John D. Phillips, Chloe R. Skidmore, Craig H. Selzman
Format: Article
Idioma:English
Publicat: BMC 2023-12-01
Col·lecció:BMC Infectious Diseases
Matèries:
Human amniotic fluid
COVID-19
Coronavirus
SARS-CoV2
Inflammation
Accés en línia:https://doi.org/10.1186/s12879-023-08856-y

Internet

https://doi.org/10.1186/s12879-023-08856-y

Ítems similars